Results
News
For years, multinational companies had little interest in lower-end consumers, figuring no money was to be made. Now, they are increasingly attractive to all types of industries, from consumer product makers to technology businesses.
Multinational Companies Court Lower-Income ConsumersNews
The Security Council, in its first emergency meeting on a public health crisis, declared the Ebola outbreak in West Africa a threat to peace and security and announced that the United Nations will deploy a new emergency health mission.
UN announces mission to combat Ebola, declares outbreak ‘threat to peace and security’News
Assuming countries across the world can muster the political will to actually make bold, sustained commitments to ending poverty, providing decent jobs, providing universal health coverage, and reducing greenhouse gas emissions, there is still the question of how to pay for it.
The Role of Private Sector Investment in Climate ChangeNews
Blood from Ebola survivors is rich with antibodies against the deadly virus, and since there is currently no approved drug to fight it, some have become desperate enough to take fate into their own hands and turn to the black market for an experimental serum made with survivors' blood.
The black market for Ebola survivors’ bloodBlog Post
?In Part 1 of her interview with NBHC, professor Patricia Danzon of The Wharton School, University of Pennsylvania laid out some of the advantages of differential pricing in pharmaceuticals. In Part 2, she describes how the concept works in practice, including the key role of politics in its implementation.
How Price Discrimination is Good for Global Health (Part 2): Patricia Danzon describes how the concept, despite its theoretical upside, ‘is not working very well’ in practiceNews
The World Health Organization is pleading for a global investment of nearly $1 billion to fight the spread of Ebola, warning that the amount is merely the minimum needed to keep infections of the deadly virus "within the tens of thousands."
WHO: $1 billion needed to keep Ebola infections within the ‘tens of thousands’Blog Post
Professor Patricia Danzon of The Wharton School, University of Pennsylvania, discusses differential pricing -- sometimes called price discrimination -- which she maintains increases utilization of medicines and, therefore, overall social welfare.
How Price Discrimination is Good for Global Health (Part 1): Professor Patricia Danzon of The Wharton School discusses differential pricing in pharmaceuticalsNews
At the TEDMED conference in Washington, DC, Dr. Marie-Paule Kieny, assistant director general of the World Health Organization (WHO), revealed that the organization will announce its third-ever global health initiative and policy in October. The initiative this time is around needle safety
WHO to Start New Global Health Initiative For Needle Safety
